Global and Japan Abdominal Aortic Aneurysm Drug Market Insights, Forecast to 2026

Global and Japan Abdominal Aortic Aneurysm Drug Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Abdominal Aortic Aneurysm Drug Product Introduction
1.2 Market Segments
1.3 Key Abdominal Aortic Aneurysm Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type
1.4.2 BSN-908
1.4.3 Canakinumab
1.4.4 CT-2009
1.4.5 Ticagrelor
1.4.6 Others
1.5 Market by Application
1.5.1 Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Abdominal Aortic Aneurysm Drug Market Size, Estimates and Forecasts
2.1.1 Global Abdominal Aortic Aneurysm Drug Revenue 2015-2026
2.1.2 Global Abdominal Aortic Aneurysm Drug Sales 2015-2026
2.2 Global Abdominal Aortic Aneurysm Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Abdominal Aortic Aneurysm Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Abdominal Aortic Aneurysm Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Abdominal Aortic Aneurysm Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Region (2021-2026)
3 Global Abdominal Aortic Aneurysm Drug Competitor Landscape by Players
3.1 Global Top Abdominal Aortic Aneurysm Drug Sales by Manufacturers
3.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Abdominal Aortic Aneurysm Drug Manufacturers by Revenue
3.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Abdominal Aortic Aneurysm Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Abdominal Aortic Aneurysm Drug Revenue in 2019
3.2.5 Global Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Abdominal Aortic Aneurysm Drug Price by Manufacturers
3.4 Global Abdominal Aortic Aneurysm Drug Manufacturing Base Distribution, Product Types
3.4.1 Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Abdominal Aortic Aneurysm Drug Product Type
3.4.3 Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Abdominal Aortic Aneurysm Drug Market Size by Type (2015-2020)
4.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020)
4.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020)
4.1.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Abdominal Aortic Aneurysm Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Type (2021-2026)
4.2.3 Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Abdominal Aortic Aneurysm Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Abdominal Aortic Aneurysm Drug Market Size by Application (2015-2020)
5.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020)
5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2015-2020)
5.1.3 Abdominal Aortic Aneurysm Drug Price by Application (2015-2020)
5.2 Abdominal Aortic Aneurysm Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Abdominal Aortic Aneurysm Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Abdominal Aortic Aneurysm Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Abdominal Aortic Aneurysm Drug Sales YoY Growth 2015-2026
6.1.2 Japan Abdominal Aortic Aneurysm Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Abdominal Aortic Aneurysm Drug Market Share in Global Market 2015-2026
6.2 Japan Abdominal Aortic Aneurysm Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Abdominal Aortic Aneurysm Drug Players by Sales (2015-2020)
6.2.2 Japan Top Abdominal Aortic Aneurysm Drug Players by Revenue (2015-2020)
6.3 Japan Abdominal Aortic Aneurysm Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Abdominal Aortic Aneurysm Drug Price by Type (2015-2020)
6.4 Japan Abdominal Aortic Aneurysm Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Abdominal Aortic Aneurysm Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Abdominal Aortic Aneurysm Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Abdominal Aortic Aneurysm Drug Price Forecast by Type (2021-2026)
6.5 Japan Abdominal Aortic Aneurysm Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Abdominal Aortic Aneurysm Drug Price by Application (2015-2020)
6.6 Japan Abdominal Aortic Aneurysm Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Abdominal Aortic Aneurysm Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Abdominal Aortic Aneurysm Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Abdominal Aortic Aneurysm Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
7.2 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country
7.2.1 North America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020)
7.2.2 North America Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
8.2 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country
8.2.1 Europe Abdominal Aortic Aneurysm Drug Sales by Country
8.2.2 Europe Abdominal Aortic Aneurysm Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
10.2 Latin America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country
10.2.1 Latin America Abdominal Aortic Aneurysm Drug Sales by Country
10.2.2 Latin America Abdominal Aortic Aneurysm Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country
11.2.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca Plc
12.1.1 AstraZeneca Plc Corporation Information
12.1.2 AstraZeneca Plc Description and Business Overview
12.1.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
12.1.5 AstraZeneca Plc Recent Development
12.2 Carolus Therapeutics, Inc.
12.2.1 Carolus Therapeutics, Inc. Corporation Information
12.2.2 Carolus Therapeutics, Inc. Description and Business Overview
12.2.3 Carolus Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Products Offered
12.2.5 Carolus Therapeutics, Inc. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Corporation Information
12.3.2 Novartis AG Description and Business Overview
12.3.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Products Offered
12.3.5 Novartis AG Recent Development
12.4 Vida Therapeutics Inc.
12.4.1 Vida Therapeutics Inc. Corporation Information
12.4.2 Vida Therapeutics Inc. Description and Business Overview
12.4.3 Vida Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Products Offered
12.4.5 Vida Therapeutics Inc. Recent Development
12.11 AstraZeneca Plc
12.11.1 AstraZeneca Plc Corporation Information
12.11.2 AstraZeneca Plc Description and Business Overview
12.11.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Products Offered
12.11.5 AstraZeneca Plc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Abdominal Aortic Aneurysm Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Abdominal Aortic Aneurysm Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Abdominal Aortic Aneurysm Drug Market Segments
Table 2. Ranking of Global Top Abdominal Aortic Aneurysm Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BSN-908
Table 5. Major Manufacturers of Canakinumab
Table 6. Major Manufacturers of CT-2009
Table 7. Major Manufacturers of Ticagrelor
Table 8. Major Manufacturers of Others
Table 9. Global Abdominal Aortic Aneurysm Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Abdominal Aortic Aneurysm Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Abdominal Aortic Aneurysm Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Abdominal Aortic Aneurysm Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Abdominal Aortic Aneurysm Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Abdominal Aortic Aneurysm Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Abdominal Aortic Aneurysm Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2019)
Table 19. Abdominal Aortic Aneurysm Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Abdominal Aortic Aneurysm Drug Price (2015-2020) (USD/Pcs)
Table 22. Abdominal Aortic Aneurysm Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Abdominal Aortic Aneurysm Drug Product Type
Table 24. Date of International Manufacturers Enter into Abdominal Aortic Aneurysm Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Abdominal Aortic Aneurysm Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2015-2020)
Table 28. Global Abdominal Aortic Aneurysm Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Abdominal Aortic Aneurysm Drug Revenue Share by Type (2015-2020)
Table 30. Abdominal Aortic Aneurysm Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2026)
Table 32. Global Abdominal Aortic Aneurysm Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2015-2020)
Table 34. Global Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2026)
Table 35. Global Abdominal Aortic Aneurysm Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Abdominal Aortic Aneurysm Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Abdominal Aortic Aneurysm Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Abdominal Aortic Aneurysm Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 39. Japan Abdominal Aortic Aneurysm Drug Sales Share by Company (2015-2020)
Table 40. Japan Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2015-2020)
Table 42. Japan Abdominal Aortic Aneurysm Drug Sales Share by Type (2015-2020)
Table 43. Japan Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Abdominal Aortic Aneurysm Drug Price (K Pcs) by Type (2015-2020)
Table 45. Japan Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2021-2026)
Table 46. Japan Abdominal Aortic Aneurysm Drug Sales Share by Type (2021-2026)
Table 47. Japan Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Abdominal Aortic Aneurysm Drug Revenue Share by Type (2021-2026)
Table 49. Japan Abdominal Aortic Aneurysm Drug Price (K Pcs) by Type (2021-2026)
Table 50. Japan Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2015-2020)
Table 51. Japan Abdominal Aortic Aneurysm Drug Sales Share by Application (2015-2020)
Table 52. Japan Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2021-2026)
Table 54. Japan Abdominal Aortic Aneurysm Drug Sales Share by Application (2021-2026)
Table 55. Japan Abdominal Aortic Aneurysm Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Abdominal Aortic Aneurysm Drug Revenue Share by Application (2021-2026)
Table 57. North America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 58. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 59. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2015-2020)
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Business Overview
Table 79. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product
Table 81. AstraZeneca Plc Recent Development
Table 82. Carolus Therapeutics, Inc. Corporation Information
Table 83. Carolus Therapeutics, Inc. Description and Business Overview
Table 84. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Carolus Therapeutics, Inc. Product
Table 86. Carolus Therapeutics, Inc. Recent Development
Table 87. Novartis AG Corporation Information
Table 88. Novartis AG Description and Business Overview
Table 89. Novartis AG Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Novartis AG Product
Table 91. Novartis AG Recent Development
Table 92. Vida Therapeutics Inc. Corporation Information
Table 93. Vida Therapeutics Inc. Description and Business Overview
Table 94. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Vida Therapeutics Inc. Product
Table 96. Vida Therapeutics Inc. Recent Development
Table 97. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 98. Key Challenges
Table 99. Market Risks
Table 100. Main Points Interviewed from Key Abdominal Aortic Aneurysm Drug Players
Table 101. Abdominal Aortic Aneurysm Drug Customers List
Table 102. Abdominal Aortic Aneurysm Drug Distributors List
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Abdominal Aortic Aneurysm Drug Product Picture
Figure 2. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2020 & 2026
Figure 3. BSN-908 Product Picture
Figure 4. Canakinumab Product Picture
Figure 5. CT-2009 Product Picture
Figure 6. Ticagrelor Product Picture
Figure 7. Others Product Picture
Figure 8. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Abdominal Aortic Aneurysm Drug Report Years Considered
Figure 13. Global Abdominal Aortic Aneurysm Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Abdominal Aortic Aneurysm Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Abdominal Aortic Aneurysm Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 18. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 20. Global Abdominal Aortic Aneurysm Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Abdominal Aortic Aneurysm Drug Revenue in 2019
Figure 22. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type in 2019
Figure 25. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type in 2019
Figure 27. Global Abdominal Aortic Aneurysm Drug Market Share by Price Range (2015-2020)
Figure 28. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application in 2019
Figure 30. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application in 2019
Figure 32. Japan Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 33. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. Japan Abdominal Aortic Aneurysm Drug Market Share in Global Market 2015-2026
Figure 35. Japan 5 and 10 Largest Abdominal Aortic Aneurysm Drug Players Market Share by Revenue in Abdominal Aortic Aneurysm Drug in 2019
Figure 36. Japan Abdominal Aortic Aneurysm Drug Revenue Share by Type (2015-2020)
Figure 37. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 38. Japan Abdominal Aortic Aneurysm Drug Revenue Share by Application (2015-2020)
Figure 39. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 40. North America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. North America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 43. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 44. U.S. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. U.S. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Canada Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Canada Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Europe Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 49. Europe Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 51. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 52. Germany Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Germany Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. France Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. U.K. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region in 2019
Figure 65. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region in 2019
Figure 66. China Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Latin America Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 91. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 92. Mexico Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Abdominal Aortic Aneurysm Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Porter's Five Forces Analysis
Figure 109. Abdominal Aortic Aneurysm Drug Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs